M. Venugopalan

Inhibition of MG‐63 cell proliferation and PDGF‐stimulated cellular processes by inhibitors of phosphatidylinositol 3‐kinase

G. Bokoch, James E. Thomas, Y. Wang, 1997, Journal of cellular biochemistry.

Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

B. C. Misra, S. Wilczynski, E. Srivatsan, 1991, American journal of human genetics.

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.

A. Glasebrook, M. Venugopalan, N. Yang, 1997, Science.

Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13.

G. Evans, S. Sen, S. Wilczynski, 1998, Cancer genetics and cytogenetics.

Correction: Raloxifene Response Needs More Than an Element

A. Glasebrook, M. Venugopalan, N. Yang, 1997, Science.

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.

H W Cole, M. Sato, L. Short, 1998, Journal of medicinal chemistry.

Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene

A. Glasebrook, M. Venugopalan, N. Yang, 1996, Science.

Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.

D. P. Smith, J. E. Thomas, M. Venugopalan, 1998, Bone.

Efficacy and safety of on‐demand tadalafil for the treatment of erectile dysfunction in South‐East Asian men

W. Shen, Q. Ding, Ying-lu Guo, 2006, International journal of urology : official journal of the Japanese Urological Association.